Pharmacodynamic Results from Phase 1 Studies of GBT021601, a Next-Generation HbS Polymerization Inhibitor for Treatment of Sickle Cell Disease

Blood(2022)

引用 1|浏览5
暂无评分
关键词
sickle cell disease,gbt021601,pharmacodynamic results,next-generation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要